Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial
顺铂联合维利帕尼或安慰剂治疗转移性三阴性乳腺癌和BRCA突变相关乳腺癌（S1416）：一项随机、双盲、安慰剂对照的II期试验
期刊:Lancet Oncology
影响因子:35.9
doi:10.1016/S1470-2045(22)00739-2
Rodler, Eve; Sharma, Priyanka; Barlow, William E; Gralow, Julie R; Puhalla, Shannon L; Anders, Carey K; Goldstein, Lori; Tripathy, Debu; Brown-Glaberman, Ursa A; Huynh, Thu-Tam; Szyarto, Christopher S; Godwin, Andrew K; Pathak, Harsh B; Swisher, Elizabeth M; Radke, Marc R; Timms, Kirsten M; Lew, Danika L; Miao, Jieling; Pusztai, Lajos; Hayes, Daniel F; Hortobagyi, Gabriel N
